
Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial
Keywords: هیپرلیپیدمی; hyperlipidemia; LDL-C; mixed dyslipidemia; pitavastatin; pravastatin; risk factors;